• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于同时测定人血浆中头孢洛扎和他唑巴坦的经过验证的高效液相色谱-紫外检测方法。

Validated HPLC-UV detection method for the simultaneous determination of ceftolozane and tazobactam in human plasma.

作者信息

Ezquer-Garin Carlos, Ferriols-Lisart Rafael, Alós-Almiñana Manuel, Aguilar-Aguilar Gerardo, Belda-Nacher Javier F, Carbonell Jose-Antonio

机构信息

Institute for Health Research (INCLIVA), University Clinical Hospital of Valencia, Valencia, Spain.

Department of Pharmacy, University Clinical Hospital of Valencia, Valencia, Spain.

出版信息

Bioanalysis. 2018 Apr 1;10(7):461-473. doi: 10.4155/bio-2017-0257. Epub 2018 Apr 10.

DOI:10.4155/bio-2017-0257
PMID:29633862
Abstract

AIM

A simple, rapid, economical and sensitive HPLC-UV method was developed for the simultaneous quantification of ceftolozane and tazobactam in plasma samples.

METHODOLOGY

After deproteinization followed by a liquid-liquid back-extraction, the compounds were separated on a C18 column (150 mm × 4.6 mm, 5 μm) with UV-visible detection at 220 nm. The mobile phase consisted of acetonitrile and potassium dihydrogenphosphate buffer at pH 3.0 (8:92, v/v), delivered isocratically at a flow rate of 1.0 ml/min and at a column oven temperature of 30°C. Cefepime was used as an internal standard.

RESULTS

Linearity was achieved in the concentration range of 0.50-100.00 μg/ml for ceftolozane and 0.25-50.00 μg/ml for tazobactam. The intra- and interday precision showed good reproducibility with coefficients of variation of less than 9.26% for ceftolozane and 9.62% for tazobactam.

CONCLUSION

The sample preparation procedure avoids expensive or time-consuming steps used by other previously published methods. The methodology was validated according to standard guidelines and was used for quantification of ceftolozane and tazobactam in plasma samples from critically ill patients.

摘要

目的

建立一种简单、快速、经济且灵敏的高效液相色谱-紫外检测法,用于同时定量测定血浆样本中的头孢洛扎和他唑巴坦。

方法

经去蛋白处理后进行液-液反萃取,化合物在C18柱(150 mm×4.6 mm,5μm)上分离,于220 nm处进行紫外可见检测。流动相由乙腈和pH 3.0的磷酸二氢钾缓冲液(8:92,v/v)组成,等度洗脱,流速为1.0 ml/min,柱温箱温度为30℃。头孢吡肟用作内标。

结果

头孢洛扎在0.50 - 100.00μg/ml浓度范围内、他唑巴坦在0.25 - 50.00μg/ml浓度范围内呈线性。日内和日间精密度显示出良好的重现性,头孢洛扎的变异系数小于9.26%,他唑巴坦的变异系数小于9.62%。

结论

样品制备过程避免了其他先前发表方法中使用的昂贵或耗时步骤。该方法按照标准指南进行了验证,并用于定量测定重症患者血浆样本中的头孢洛扎和他唑巴坦。

相似文献

1
Validated HPLC-UV detection method for the simultaneous determination of ceftolozane and tazobactam in human plasma.用于同时测定人血浆中头孢洛扎和他唑巴坦的经过验证的高效液相色谱-紫外检测方法。
Bioanalysis. 2018 Apr 1;10(7):461-473. doi: 10.4155/bio-2017-0257. Epub 2018 Apr 10.
2
Development of an HPLC Method for the Determination of Ceftolozane/Tazobactam in Biological and Aqueous Matrixes.一种用于测定生物和水性基质中头孢洛扎/他唑巴坦的高效液相色谱法的开发。
J Chromatogr Sci. 2016 Jul;54(6):1037-40. doi: 10.1093/chromsci/bmw047. Epub 2016 Apr 4.
3
Determination of total and free ceftolozane and tazobactam in human plasma and interstitial fluid by HPLC-UV.采用高效液相色谱-紫外法测定人血浆和间质液中的总头孢洛扎纳和他唑巴坦。
J Pharm Biomed Anal. 2019 Jan 30;163:34-38. doi: 10.1016/j.jpba.2018.09.044. Epub 2018 Sep 24.
4
A simple and rapid RP-HPLC method for the simultaneous determination of piperacillin and tazobactam in human plasma.一种用于同时测定人血浆中哌拉西林和他唑巴坦的简单快速的反相高效液相色谱法。
J Pharm Biomed Anal. 2016 Nov 30;131:80-86. doi: 10.1016/j.jpba.2016.08.010. Epub 2016 Aug 9.
5
Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC.通过高效液相色谱法测定接受持续静脉-静脉血液滤过治疗的患者血浆和超滤液中哌拉西林和他唑巴坦的含量及稳定性。
Biomed Chromatogr. 2005 Oct;19(8):570-8. doi: 10.1002/bmc.482.
6
Pharmacokinetics and Tissue Penetration of Ceftolozane-Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers.头孢洛扎他唑巴坦在下肢感染的糖尿病患者和健康成年志愿者中的药代动力学和组织穿透性。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01449-17. Print 2017 Dec.
7
High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillin.高效液相色谱法测定血浆中游离和总他唑巴坦及哌拉西林的含量。
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jan 1;877(1-2):86-8. doi: 10.1016/j.jchromb.2008.11.010. Epub 2008 Nov 13.
8
Plasma and epithelial lining fluid pharmacokinetics of ceftolozane and tazobactam alone and in combination in mice.头孢洛扎与他唑巴坦单独及联合使用时在小鼠体内的血浆和上皮衬液药代动力学
Antimicrob Agents Chemother. 2015;59(6):3373-6. doi: 10.1128/AAC.04402-14. Epub 2015 Mar 30.
9
An improved high-performance liquid chromatographic method with a solid-phase extraction for the determination of piperacillin and tazobactam: application to pharmacokinetic study of different dosage in Chinese healthy volunteers.一种改进的高效液相色谱法结合固相萃取用于哌拉西林和他唑巴坦的测定:在中国健康志愿者中不同剂量的药代动力学研究中的应用
Biomed Chromatogr. 2007 Jul;21(7):680-6. doi: 10.1002/bmc.800.
10
A validated LC-MS/MS method for the simultaneous quantification of the novel combination antibiotic, ceftolozane-tazobactam, in plasma (total and unbound), CSF, urine and renal replacement therapy effluent: application to pilot pharmacokinetic studies.一种经验证的 LC-MS/MS 方法,用于同时定量新型组合抗生素头孢洛扎他唑巴坦在血浆(总蛋白和未结合蛋白)、CSF、尿液和肾脏替代治疗流出液中的浓度:在初步药代动力学研究中的应用。
Clin Chem Lab Med. 2020 Nov 25;59(5):921-933. doi: 10.1515/cclm-2020-1196. Print 2021 Apr 27.

引用本文的文献

1
Development of a UHPLC-UV/Vis Method for Simultaneously Determining Six Beta-Lactam Antibiotics in Plasma: A Tool for the Clinical Implementation of Therapeutic Monitoring of Beta-Lactams.开发一种用于同时测定血浆中六种β-内酰胺类抗生素的超高效液相色谱-紫外/可见分光光度法:一种用于β-内酰胺类药物治疗监测临床应用的工具。
Antibiotics (Basel). 2025 Jun 17;14(6):613. doi: 10.3390/antibiotics14060613.
2
Ceftolozane-Tazobactam Pharmacokinetics in the Abdominal Tissue of Patients Undergoing Lower Gastrointestinal Surgery: Dosing Considerations Based on Site-Specific Pharmacodynamic Target Attainment.头孢托罗-他唑巴坦在下消化道手术患者腹部组织中的药代动力学:基于部位特异性药效学靶点达到情况的给药考量
Infect Dis Ther. 2023 Jan;12(1):193-207. doi: 10.1007/s40121-022-00720-x. Epub 2022 Nov 24.